APA (7th ed.) Citation

Chisako Fujiwara, Akihiko Uchiyama, Yuta Inoue, Mai Ishikawa, & Sei‐ichiro Motegi. (2023). Real‐world effectiveness and safety of dupilumab in patients with moderate and severe atopic dermatitis: 2‐year experience. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Chisako Fujiwara, Akihiko Uchiyama, Yuta Inoue, Mai Ishikawa, and Sei‐ichiro Motegi. Real‐world Effectiveness and Safety of Dupilumab in Patients with Moderate and Severe Atopic Dermatitis: 2‐year Experience. Frontiers Media S.A., 2023.

MLA (9th ed.) Citation

Chisako Fujiwara, et al. Real‐world Effectiveness and Safety of Dupilumab in Patients with Moderate and Severe Atopic Dermatitis: 2‐year Experience. Frontiers Media S.A., 2023.